Abbott Laboratories is rated a Buy due to growth indicators, diversified portfolio, strong profit margin. Read an investment ...

A federal appeals court trimmed a whistleblower’s once-defeated False Claims Act suit Friday alleging Abbott Laboratories Inc ...

Abbott Laboratories engages in the discovery ... Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international ...

In a report released on December 20, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...

Abbott is one of the biggest healthcare companies in the world. With over 400 consecutive quarterly dividend payouts and 53 ...

Abbott Laboratories (NYSE:ABT) manufacturers and sells medical and healthcare related products in more than 160 countries. Originally started by Dr. Wallace Abbott as a means of developing high ...

In a report released today, Adam Maeder from Piper Sandler maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

The Zacks Medical - Products industry, to which Abbott belongs, has gained 1% over this period. Now the key question is: Where could the stock be headed in the near term? Although media reports or ...

This report presents key facts and figures about U.S.-based diversified healthcare company Abbott ... Laboratories. It shows the company's role in a global perspective, but also revenues, major ...

Abbott Laboratories has established itself as a ... spans multiple segments within the healthcare industry, including medical devices, diagnostics, nutrition, and established pharmaceuticals.